We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
-7.31%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$226M
AUM Growth
-$27.9M
Cap. Flow
+$15.4M
Cap. Flow %
6.82%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RNTX
Rein Therapeutics
RNTX
+$15.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMWL icon
1
American Well
AMWL
$180M
$109M 48.42%
315,039
– –
ANNX icon
2
Annexon
ANNX
$834M
$54.4M 24.08%
1,954,978
– –
RNTX
3
Rein Therapeutics
RNTX
$63.1M
$23.8M 10.51%
830,472
+450,000
+118% +$15.4M
AKBA icon
4
Akebia Therapeutics
AKBA
$354M
$15.7M 6.97%
4,652,561
– –
ASMB icon
5
Assembly Biosciences
ASMB
$498M
$10.2M 4.53%
185,625
– –
WHWK
6
Whitehawk Therapeutics
WHWK
$190M
$7.25M 3.21%
374,789
– –
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.15M 2.28%
126,270
– –

Similar funds

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
AFA
Atlas Financial Advisors Oroville, California $64.1M AUM 8.36% 1-Year Est. Return
MCC
Maiden Cove Capital Cape Elizabeth, Maine $65.4M AUM
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
MC
Meketa Capital Westwood, Massachusetts $44.6M AUM
OAM
Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return
IP
Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return
JCP
Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

Alerce Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Alerce Investment Management held 7 positions worth $226M, down 11% from $254M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Alerce Investment Management deployed $15.4M of net new capital in Q1 2021, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management added most to Rein Therapeutics in Q1 2021, an estimated $15.4M increase.
  • Alerce Investment Management's ten largest holdings make up 100% of its $226M portfolio in Q1 2021.
  • Alerce Investment Management opened 0 new positions and closed 0 in Q1 2021.
  • Alerce Investment Management's portfolio value fell 11% quarter-over-quarter to $226M.

Based on Alerce Investment Management's 13F filing for Q1 2021, filed 12 May 2021.